EUVIMEDEUVIMED entdecken
Open Access

Pregnancy-Associated Extracorporeal Membrane Oxygenation in the United States

Megan S Varvoutis, Lauren E Wein, Ronan Sugrue, Kristin C Darwin iD, Arthur J Vaught, Marie-Louise Meng, Brenna L Hughes, Chad A Grotegut, Jerome J Federspiel iD

American Journal of Perinatology · 01.05.2024 · 41 (S 01 S 01) · e1248-e1256

DOI: 10.1055/a-2008-8462 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Perinatology, erschienen am 01.05.2024. Verfasst von Megan S Varvoutis und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, West Virginia University, Morgantown, West Virginia. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, COVID-19, Length of Stay, Hospital Mortality. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, UL1TR002553, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The use of extracorporeal membrane oxygenation (ECMO) therapy has increased in the adult population. Studies from the H1N1 influenza pandemic suggest that ECMO deployment in pregnancy is associated with favorable outcomes. With increasing numbers of pregnant women affected by COVID-19 (coronavirus disease 2019) and potentially requiring this life-saving therapy, we sought to compare comorbidities, costs, and outcomes between pregnancy- and nonpregnancy-associated ECMO therapy among reproductive-aged female patients. Study Design We used the 2013 to 2019 National Readmissions Database. Diagnosis and procedural coding were used to identify ECMO deployment, potential indications, comorbid conditions, and pregnancy outcomes. The primary outcome was in-hospital mortality during the patient's initial ECMO stay. Secondary outcomes included length of stay and hospital charges/costs, occurrence of thromboembolic or bleeding complications during ECMO hospitalization, and mortality and readmissions up to 330 days following ECMO stay. Univariate and multivariate regression models were used to model the associations between pregnancy status and outcomes.

Results

The sample included 324 pregnancy-associated hospitalizations and 3,805 nonpregnancy-associated hospitalizations, corresponding to national estimates of 665 and 7,653 over the study period, respectively. Pregnancy-associated ECMO had lower incidence of in-hospital death (adjusted odds ratio [aOR]: 0.56, 95% confidence interval [CI]: 0.41–0.75) and bleeding complications (aOR: 0.67, 95% CI: 0.49–0.93). Length of stay was significantly shorter (adjusted rate ratio (aRR): 0.86, 95% CI: 0.77–0.96) and total hospital costs were less (aRR: 0.83, 95% CI: 0.75–0.93). Differences in the incidence of thromboembolic events (aOR: 1.04, 95% CI: 0.78–1.38) were not statistically significant.

Conclusion

Pregnancy-associated ECMO therapy had lower incidence of in-hospital death, bleeding complications, total inpatient cost, and length of stay when compared with nonpregnancy-associated ECMO therapy without increased thromboembolic complications. Pregnancy-associated ECMO therapy should be offered to eligible patients. Key Points

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracorporeal Membrane OxygenationCOVID-19Length of StayHospital MortalityHumansPregnancyFemaleUnited StatesAdultPatient ReadmissionPregnancy OutcomePregnancy ComplicationsSARS-CoV-2Young AdultHospital CostsDatabases, Factual

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, West Virginia University, Morgantown, West Virginia.
  • Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, North Carolina.
  • Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Department of Anesthesiology, Duke University School of Medicine, Durham, North Carolina.
  • Department of Obstetrics and Gynecology, Wake Forest University, Winston-Salem, North Carolina.

ORCID-Profile: Kristin C Darwin, Jerome J Federspiel

Förderung

  • NCATS NIH HHS
  • UL1TR002553
  • National Center for Advancing Translational Sciences
  • Foundation for Women and Girls with Blood Disorders

Zitieren

APA

Varvoutis, M. S., Wein, L. E., Sugrue, R., Darwin, K. C., Vaught, A. J., Meng, M. L., Hughes, B. L., Grotegut, C. A., & Federspiel, J. J. (2024). Pregnancy-Associated Extracorporeal Membrane Oxygenation in the United States. American Journal of Perinatology, 41(S 01 S 01), e1248-e1256. https://doi.org/10.1055/a-2008-8462

Vancouver

Varvoutis MS, Wein LE, Sugrue R, Darwin KC, Vaught AJ, Meng ML, et al. Pregnancy-Associated Extracorporeal Membrane Oxygenation in the United States. American Journal of Perinatology. 2024;41(S 01 S 01):e1248-e1256. doi:10.1055/a-2008-8462

BibTeX
@article{Varvoutis2024,
  author = {Varvoutis, Megan S and Wein, Lauren E and Sugrue, Ronan and Darwin, Kristin C and Vaught, Arthur J and Meng, Marie-Louise and Hughes, Brenna L and Grotegut, Chad A and Federspiel, Jerome J},
  title = {Pregnancy-Associated Extracorporeal Membrane Oxygenation in the United States},
  journal = {American Journal of Perinatology},
  year = {2024},
  volume = {41},
  number = {S 01 S 01},
  pages = {e1248--e1256},
  doi = {10.1055/a-2008-8462}
}
Kostenlos starten →